Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H, Wesseling J, Boezen HM, van der Graaf WT. Hartog H, et al. Among authors: boezen hm. Eur J Cancer. 2007 Sep;43(13):1895-904. doi: 10.1016/j.ejca.2007.05.021. Epub 2007 Jul 10. Eur J Cancer. 2007. PMID: 17624760 Review.
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin.
van Tol KM, Jager PL, de Vries EG, Piers DA, Boezen HM, Sluiter WJ, Dullaart RP, Links TP. van Tol KM, et al. Among authors: boezen hm. Eur J Endocrinol. 2003 Jun;148(6):589-96. doi: 10.1530/eje.0.1480589. Eur J Endocrinol. 2003. PMID: 12773129
Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.
Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S. Spierings DC, et al. Among authors: boezen hm. Clin Cancer Res. 2003 Aug 15;9(9):3397-405. Clin Cancer Res. 2003. PMID: 12960128
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.
Wachters FM, Van Putten JW, Kramer H, Erjavec Z, Eppinga P, Strijbos JH, de Leede GP, Boezen HM, de Vries EG, Groen HJ. Wachters FM, et al. Among authors: boezen hm. Br J Cancer. 2003 Oct 6;89(7):1192-9. doi: 10.1038/sj.bjc.6601283. Br J Cancer. 2003. PMID: 14520444 Free PMC article. Clinical Trial.
Phase II study of docetaxel and carboplatin as second-line treatment in NSCLC.
Wachters FM, van Putten JW, Boezen HM, Groen HJ. Wachters FM, et al. Among authors: boezen hm. Lung Cancer. 2004 Aug;45(2):255-62. doi: 10.1016/j.lungcan.2004.02.006. Lung Cancer. 2004. PMID: 15246198 Clinical Trial.
Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.
Briët JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, Pras E, Boezen HM, van der Zee AG, Nijman HW. Briët JM, et al. Among authors: boezen hm. Gynecol Oncol. 2005 Mar;96(3):799-804. doi: 10.1016/j.ygyno.2004.11.033. Gynecol Oncol. 2005. PMID: 15721428
A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma.
De Vos FY, Bos AM, Schaapveld M, de Swart CA, de Graaf H, van der Zee AG, Boezen HM, de Vries EG, Willemse PH. De Vos FY, et al. Among authors: boezen hm. Gynecol Oncol. 2005 Apr;97(1):60-7. doi: 10.1016/j.ygyno.2004.11.052. Gynecol Oncol. 2005. PMID: 15790438 Clinical Trial.
Differential desensitization of homozygous haplotypes of the beta2-adrenergic receptor in lymphocytes.
Oostendorp J, Postma DS, Volders H, Jongepier H, Kauffman HF, Boezen HM, Meyers DA, Bleecker ER, Nelemans SA, Zaagsma J, Meurs H. Oostendorp J, et al. Among authors: boezen hm. Am J Respir Crit Care Med. 2005 Aug 1;172(3):322-8. doi: 10.1164/rccm.200409-1162OC. Epub 2005 May 5. Am J Respir Crit Care Med. 2005. PMID: 15879418 Free PMC article.
Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis.
Links TP, van Tol KM, Jager PL, Plukker JT, Piers DA, Boezen HM, Dullaart RP, de Vries EG, Sluiter WJ. Links TP, et al. Among authors: boezen hm. Endocr Relat Cancer. 2005 Jun;12(2):273-80. doi: 10.1677/erc.1.00892. Endocr Relat Cancer. 2005. PMID: 15947102
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors.
de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Oosterom E, Bruinenberg M, Steege Gv, Oosterwijk JC, van der Hout AH, Boezen HM, Schaapveld M, Kleibeuker JH, de Vries EG. de Jong MM, et al. Among authors: boezen hm. Eur J Cancer. 2005 Aug;41(12):1819-23. doi: 10.1016/j.ejca.2005.04.035. Eur J Cancer. 2005. PMID: 16043347
258 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback